SKYE
Skye Bioscience, Inc.
Latest Form 4:Sale$114KbySchwab Andrew J. (Director, 10% Owner) · filed Aug 20, 2026
Skye Bioscience, Inc. (SKYE) has 3 SEC Form 4 filings (19 transaction rows) in the rolling window, disclosed by 2 distinct insiders. Most recent filing: Aug 20, 2026.
The most active filer is Director, 10% Owner Schwab Andrew J. with 3 filings. Insiders have net sold $281K over the trailing 6 months.
- Industry:Biotechnology
- CEO:Punit Dhillon
- Employees:12
- HQ:San Diego, CA, US
- IPO:2015-01-06
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$281K
reported sales (SEC code S)
Unique Insiders
2
in the rolling window
Market Cap
$12.6M
latest known value
| Source | ||||||
|---|---|---|---|---|---|---|
Schwab Andrew J.First filing | Director, 10% Owner | Sale | 300,000 | $114K | Aug 20 | SEC ↗ |
Schwab Andrew J.First filing | Director, 10% Owner | Sale | 68,140 | $24K | Aug 20 | SEC ↗ |
Schwab Andrew J.First filing | Director, 10% Owner | Sale | 7,700 | $2K | Aug 20 | SEC ↗ |
5AM Partners VII, LLCFirst filing | 10% Owner | Sale | 300,000 | $114K | Aug 20 | SEC ↗ |
5AM Partners VII, LLCFirst filing | 10% Owner | Sale | 68,140 | $24K | Aug 20 | SEC ↗ |
5AM Partners VII, LLCFirst filing | 10% Owner | Sale | 7,700 | $2K | Aug 20 | SEC ↗ |
Related companies
Skye Bioscience, Inc. is in the Healthcare sector.